*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients
*
5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence
54321
Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.
*
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied
54321
Allogeneic Hematopoietic Stem Cell Transplantation in 2023 - Robert Soiffer, M.D.
Novel Treatment Approaches of Graft-Versus-Host Disease - Corey Cutler, M.D.
CD34+-Selected Allografts as Platform for Adoptive Immunotherapy - Guenther Koehne, M.D., Ph.D.
Lessons in Diversity from Investigating Cord Blood as an Alternative Stem Cell Source - Juliet Barker, MBBS, FRACP
Next Steps in CAR T-Cell Therapies - Michel Sadelain, M.D., Ph.D
Do We Need a CAR T Registry? - Marcelo Pasquini, M.D.
The Role of Intestinal Microbiome in Cancer Immunotherapy - Marcel van den Brink, M.D., Ph.D.
Immunotherapeutic Approaches to Undruggable Leukemia Targets - David Scheinberg M.D., Ph.D.
Lung Stem Cells for Lung Regeneration - Yair Reisner, Ph.D.
*
*
*
*
*
*
*
*
Choose 1 option
*
Hours attended